article thumbnail

A Forthcoming Shift of Pharmaceutical Sales Compensation Plans?

OpenSymmetry

Sales in the pharmaceutical industry has been a rigid and consistent business. However, a recent article from the Harvard Business Review suggests the stagnant methods of pharmaceutical sales rep compensation may be the root cause of an even bigger public health issue. Share your thoughts in the comments below!

article thumbnail

A Forthcoming Shift of Pharmaceutical Sales Compensation Plans?

OpenSymmetry

Sales in the pharmaceutical industry has been a rigid and consistent business. However, a recent article from the Harvard Business Review suggests the stagnant methods of pharmaceutical sales rep compensation may be the root cause of an even bigger public health issue. Share your thoughts in the comments below!

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

2021 Job Market: Watch for Funding, Flexibility, and Diversity

Zoominfo

Other industries with strong funding in 2020 included the pharmaceutical and energy fields. Further sweetening the deal, impact investing — in other words, funds aimed at a social cause — will benefit nonprofits in 2021 given the economic, environmental, and racial upheavals in the U.S. Want to work for an innovative company?

Nonprofit 246
article thumbnail

Would You Like to be Selling Guns Right Now?

Understanding the Sales Force

Pharmaceutical companies lobby to fast track drug approvals that allow doctors to prescribe poisonous treatments that we inhale like candy and become even sicker. If we have to put the blame somewhere, let's put it on our dysfunctional, bought and paid for, corrupt government and the media that amplifies the outrage, and let's fix it.

article thumbnail

Lesson Learned: 4 Things You Can Learn from Business Failures

Pipeliner

What followed was the Great Recession that prompted the US federal government to bail out certain companies, mostly banks, whose failure may disrupt the whole economy. Interestingly, Kodak is moving to pharmaceuticals with a $765 million loan from the government. The lesson: Too much, too late.

Banking 87
article thumbnail

Pharma sales – it’s a different world

Sales Training Connection

On the other side of the table with fewer sales reps seeing physicians face-to-face, physicians have come to accept the new normal – fewer free office lunches, reduction in paid speaker programs, and cuts in dollars paid for pharmaceutical and marketing research. Pay-for-performance is on the rise. Regulators are becoming more risk-averse.

article thumbnail

2021 Job Market: Watch for Funding, Flexibility, and Diversity

Zoominfo

Other industries with strong funding in 2020 included the pharmaceutical and energy fields. Further sweetening the deal, impact investing — in other words, funds aimed at a social cause — will benefit nonprofits in 2021 given the economic, environmental, and racial upheavals in the U.S. Want to work for an innovative company?

Nonprofit 130